Leandra

Ethinylestradiol, the active ingredient in Leandra, is a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy in women of reproductive age by suppressing ovulation and altering cervical mucus. GNH USA supplies Leandra as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Leandra, a combined oral contraceptive, acts on the hormonal regulation of the menstrual cycle. - Contraception: Prevents pregnancy by inhibiting ovulation and modifying cervical mucus. - Menstrual cycle regulation: Provides predictable monthly bleeding and reduces irregular periods. - Acne treatment: Improves moderate acne associated with androgen excess in women.

Leandra may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild stomach upset, often resolves with continued use. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: swelling or discomfort in the breasts. - Spotting or breakthrough bleeding: irregular light bleeding. - Mood changes: irritability or mild depression. - Weight gain: modest increase in body weight.

Serious or Rare Side Effects: - Venous thromboembolism: deep‑vein clot formation. - Pulmonary embolism: clot migration to the lungs. - Stroke: cerebrovascular accident, especially in high‑risk individuals. - Myocardial infarction: heart attack risk in susceptible patients. - Severe hypertension: sudden rise in blood pressure. - Liver tumor: benign hepatic adenoma development.

Before prescribing Leandra, clinicians should evaluate patient risk factors and counsel on safe use. - Smoking: avoid use in women over 35 who smoke due to increased clot risk. - History of thromboembolism: contraindicated in patients with prior clotting events. - Liver disease: use with caution in active liver disease or dysfunction. - Hypertension: monitor blood pressure regularly; discontinue if uncontrolled. - Drug interactions: review concomitant medications that may reduce efficacy. - Store at ambient temperature: keep below 25°C, protect from moisture and keep in original packaging.

Leandra can interact with several medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin): may markedly reduce contraceptive efficacy. - Other estrogen‑containing products (e.g., hormone replacement therapy): increase risk of thrombotic events. - Anticoagulants (e.g., warfarin): may enhance clotting risk.

Moderate Interactions (Monitor Closely): - Antifungals such as ketoconazole: may increase hormone levels. - Antiretrovirals (e.g., efavirenz): may lower contraceptive effectiveness. - St. John's wort: may modestly reduce hormone concentrations. - Certain antibiotics (e.g., griseofulvin): may slightly diminish efficacy.